Ross E. Elfand

Monopolization

• Graco v. Carlisle – Successfully represented Graco as one of the lead attorneys in an eight-day jury trial, securing a first-of-its kind jury verdict in Graco’s favor rejecting the fraud and antitrust Walker Process counterclaims enti
• Live Sports Betting Patent and Antitrust Litigation – Represented the plaintiff as one of the lead antitrust lawyers in litigation against sports betting streaming technology companies.
• Regeneron v. Novartis – Represented Novartis as co-lead counsel in antitrust litigation involving Walker Process monopolization claims relating to a patent covering syringes prefilled with an anti-VEGF drug that treats ophthalmic conditions.
• Rebate Wall Biosimilar Litigation – Represented Pfizer as co-lead counsel in ground-breaking antitrust litigation regarding the impact of contracting and rebating practices on biosimilars.
• In re Aggrenox Antitrust Litigation – Represented Boehringer lngelheim as co-lead counsel in class action multidistrict litigation arising from alleged delay in generic competition to Aggrenox, due to a claimed “reverse payment” patent settlem
• In re Loestrin Antitrust Litigation – Represented Warner Chilcott in class action litigation challenging the company’s settlements of patent litigation relating to the oral contraceptive Loestrin.

Cartel

• Nuclear Power Generation Antitrust Litigation – Co-lead antitrust lawyer for a defendant in an antitrust class action accusing the nuclear power generation industry of colluding to suppress employee wages and share competitiv
• In re Blue Cross Blue Shield Antitrust Litig. – Co-lead antitrust lawyer for a group of more than a dozen large healthcare providers who opted out of a $2 billion class settlement and brought their own direct antitrust litigation against the B
• In re Domestic Drywall Antitrust Litigation – Represented CertainTeed Gypsum in the homebuilders' opt-out antitrust litigation alleging price fixing among producers of drywall products.
• In re TFT-LCD (Flat Panel) Antitrust Litigation – Represented Toshiba in civil cases involving allegations of price-fixing of LCD panels, including two class actions and numerous opt-out cases. After a six-week trial where the Plaintiff allege
• State Attorneys General TFT-LCD Antitrust Litigation – Defended Toshiba as the lead for the defense group in three separate state antitrust actions filed by state attorneys general in Mississippi, Washington, and Illinois.
• Fair Isaac Corporation v. Equifax, et al. – Represented Experian Information Solutions, Inc. in an action brought by FICO, the dominant provider of consumer credit risk scoring services, against the three major U.S. credit bureaus alleging col

Global Investigations

• Represented technology companies as global counsel in competition investigations by enforcement agencies in the United States, Europe, India, Argentina, Chile, Mexico, and numerous other jurisdictions.

Ross Elfand is a seasoned antitrust trial lawyer who has served as lead counsel in high profile matters on behalf of  pharmaceutical and technology companies. He regularly represents companies as the lead advocate before competition enforcement agencies, including the Federal Trade Commission, state attorneys general offices, and other agencies around the world. 

Ross often serves as lead counsel in large-scale, complex, and high-risk matters, including multi-district cartel and monopolization cases in the United States. He is a skilled litigator of claims involving the interplay between intellectual property and antitrust laws in the pharmaceutical industry.

Ross is a trusted legal advisor on antitrust risks associated with product development, contracting, marketing, joint ventures, and patent-related issues. He also advises companies in the technology industry regarding the intersection of global privacy and competition laws.